Medical device manufacturers are increasingly adopting continuous software update strategies post-launch, requiring seamless collaboration between engineering, quality assurance, cybersecurity, and regulatory teams. A comprehensive analysis of 25 leading software providers reveals that successful implementation demands integrated digital workflows enabling real-time coordination. This shift addresses the industry's need for agile development practices while maintaining compliance with FDA regulations and ensuring patient safety through coordinated post-market surveillance and security protocols.

Summary auto-generated by AI from the original publisher's content. Editorial standards.